Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - University of Edinburgh announces directorship of the National Creutzfeldt-Jakob Disease surveillance unit:

This article was originally published in Clinica

Executive Summary

The University of Edinburgh has announced that James Ironside has assumed directorship of the National Creutzfeldt-Jakob Disease surveillance unit. Professor Ironside's appointment is in accordance with recent management restructuring plans, whereby directorship of the unit must be rotated amongst the key management members. The other participants in the three-year tenure rotation scheme are fellow consultant neurologists Robert Will, who was director since the founding of the unit in 1990, and Richard Knight, who has been appointed to the newly-created position of deputy director.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064397

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel